Opening Asia for Russia

Sinopharm to start clinical trials of third vaccine

10.04.2021 101 просмотров

China has approved Sinopharm's third coronavirus vaccine for clinical trials.


Chinese authorities have approved the third coronavirus vaccine developed by the national pharmaceutical company Sinopharm for clinical trials. This is stated in an official statement published on Saturday on her social network page "Weibo".

"This is a recombinant vaccine containing elements of the coronavirus spike protein," it specifies. According to the statement, the new drug "has enhanced properties to stimulate the immune defense of the body."

According to official data, in addition to the mentioned novelty, five more drugs for coronavirus have been developed in China: three inactivated, adenovirus and recombinant protein ones. They are intended for vaccination in one, two or three stages.

Новости партнёров